Klozapin Accord (Clozapine)

Clozapine blocks dopamine D2 receptors and serotonin 5‑HT2A receptors while also influencing several other neurotransmitter systems. This broad antagonism helps to balance dopamine and serotonin activity in the brain, reducing psychotic symptoms and improving mood stability.

The appropriate dose of Klozapin Accord is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage adjustments are made according to clinical guidelines and patient monitoring.

Clozapine is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out. It should only be used during pregnancy if the potential benefit justifies the potential risk. Clozapine is excreted in breast milk, so breastfeeding is generally not recommended while on therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with many typical and atypical antipsychotics, clozapine is uniquely effective for treatment‑resistant schizophrenia but carries a higher risk of serious blood‑related side effects such as agranulocytosis. Its broader receptor profile also leads to distinct metabolic and cardiovascular effects, requiring more intensive monitoring than most other agents.

Store Klozapin Accord tablets at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Klozapin Accord is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water, and the dosing schedule should be followed consistently to maintain stable blood levels.

The most critical risks include agranulocytosis (a severe drop in white blood cells), myocarditis (inflammation of the heart muscle), seizures, and profound metabolic disturbances. Regular blood monitoring, cardiac assessments, and vigilance for signs of infection or cardiac symptoms are essential.

Klozapin Accord is contraindicated in patients with known hypersensitivity to clozapine or any of its excipients, those with a history of uncontrolled epilepsy, severe central nervous system depression, or existing agranulocytosis. Caution is also advised for individuals with significant cardiac disease, uncontrolled diabetes, or severe hepatic impairment.